Bio-Techne Corporation TECH
Set alert
72.69 USD +0.02 +0.02%
As of Nov 3, 11:30 AM ET
72.67 Day range 72.72
43.30 52-week range 72.71
- YTD
- +23.59%
- 1 year
- +18.65%
- Open
- 72.72
- Prev close
- 72.67
- Mkt cap
- 11.42B
- Vol
- 1.01M
- Avg vol
- 2.80M
- EPS
- 1.16
- P/E
- 62.66
- Div yield
- 0.44%
More statistics
- Low
- 72.67
- High
- 72.72
- Forward P/E
- 31.44
- Beta
- 1.27
- Short ratio
- 2.42
- Inst. own
- 112.42%
- Dividend
- 0.32
- Ex-div date
- Aug 23, 2026
- Earnings
- Nov 4, 2026
- 50-d avg
- 72.45
- 200-d avg
- 63.16
- 1y target
- 70.50
5Y chart
Events in this range
- Nov 10, 2021Dividend: 0.32
- Nov 11, 2021Dividend: 0.32
- Feb 10, 2022Dividend: 0.32
- May 13, 2022Dividend: 0.32
- Aug 12, 2022Dividend: 0.32
- Nov 10, 2022Dividend: 0.32
- Nov 11, 2022Dividend: 0.32
- Nov 28, 2022Dividend: 0.32
- Nov 30, 2022Split: 4 for 1
- Feb 10, 2023Dividend: 0.08
- May 12, 2023Dividend: 0.08
- Aug 17, 2023Dividend: 0.08
- Nov 9, 2023Dividend: 0.08
- Feb 9, 2024Dividend: 0.08
- May 10, 2024Dividend: 0.08
- Aug 19, 2024Dividend: 0.08
- Nov 8, 2024Dividend: 0.08
- Feb 14, 2025Dividend: 0.08
- May 19, 2025Dividend: 0.08
- Aug 6, 2025Earnings: 0.53; estimate 0.5; surprise 6%
- Aug 18, 2025Dividend: 0.08
- Nov 5, 2025Earnings: 0.42; estimate 0.4214; surprise -0.33%
- Nov 17, 2025Dividend: 0.08
- Feb 4, 2026Earnings: 0.46; estimate 0.43; surprise 6.98%
- Feb 13, 2026Dividend: 0.08
- May 6, 2026Earnings: 0.53; estimate 0.55; surprise -3.64%
- May 18, 2026Dividend: 0.08
- Jun 26, 2026Downgrade: Stephens & Co. · Overweight → Equal-Weight
- Jun 29, 2026Downgrade: Citigroup · Buy → Neutral
- Jun 30, 2026Downgrade: Benchmark · Buy → Hold
- Jun 30, 2026Downgrade: TD Cowen · Buy → Hold
- Jul 9, 2026Downgrade: RBC Capital · Outperform → Sector Perform
- Aug 12, 2026Earnings: 0.52; estimate 0.519; surprise 0.19%
- Aug 13, 2026Downgrade: Wells Fargo · Overweight → Equal-Weight
- Aug 17, 2026Dividend: 0.08
- Aug 24, 2026Dividend: 0.08
- Nov 4, 2026Earnings: —; estimate 0.44; surprise —%
Signals (122)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 5, 2026 | 4 weeks ago |
| SMA: Bullish | Jun 15, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 15, 2026 | 4 months ago |
| SMA: Bullish | Jun 8, 2026 | 4 months ago |
| SMA: Bearish | May 4, 2026 | 6 months ago |
| SMA: Bullish | Apr 27, 2026 | 6 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| SMA: Bearish | Feb 16, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 16, 2026 | 8 months ago |
| SMA: Bearish | Feb 9, 2026 | 8 months ago |
| SMA: Bullish | Jan 5, 2026 | 10 months ago |
| MACD: Buy Signal | Jan 5, 2026 | 10 months ago |
| MACD: Sell Signal | Dec 29, 2025 | 10 months ago |
| SMA: Bearish | Dec 8, 2025 | 11 months ago |
| SMA: Bullish | Nov 10, 2025 | 11 months ago |
| SMA: Bearish | Nov 3, 2025 | 1 year ago |
| SMA: Bullish | Sep 29, 2025 | 1 year ago |
| SMA: Bullish | Sep 29, 2025 | 1 year ago |
| SMA: Bearish | Sep 8, 2025 | 1 year ago |
Newest 20 of 122.
Analyst view
Consensus: hold
Hold
Price target (mean) 70.50 -3.0% downside
Now 72.69
- Target (low)
- 50.00
- Target (mean)
- 70.50
- Target (high)
- 73.00
Ratings (0m) 13 0 buy · 12 hold · 1 sell
- Strong buy0
- Buy0
- Hold12
- Sell1
- Strong sell0
Recommendation trend
- This month 13
- 1 month ago 13
- 2 months ago 14
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.44764 | 0.41 – 0.49 | 0.42 | +6.6% | 292.20M | +2.0% | 7 |
| Next quarter | 0.48138 | 0.46 – 0.51 | 0.46 | +4.7% | 307.78M | +4.0% | 6 |
| Current year | 2.04 | 1.82 – 2.15 | 1.93 | +5.5% | 1.27B | +4.4% | 13 |
| Next year | 2.31 | 2.03 – 2.60 | 2.04 | +13.5% | 1.40B | +10.1% | 10 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 13, 2026 | Wells Fargo | Downgrade | Overweight | Equal-Weight |
| Jul 9, 2026 | RBC Capital | Downgrade | Outperform | Sector Perform |
| Jun 30, 2026 | TD Cowen | Downgrade | Buy | Hold |
| Jun 30, 2026 | Benchmark | Downgrade | Buy | Hold |
| Jun 29, 2026 | Citigroup | Downgrade | Buy | Neutral |
| Jun 26, 2026 | Stephens & Co. | Downgrade | Overweight | Equal-Weight |
| Jun 26, 2026 | William Blair | Downgrade | Outperform | Market Perform |
| Jun 26, 2026 | Baird | Maintained | Neutral | Neutral |
| Jun 11, 2026 | Piper Sandler | Initiated | — | Neutral |
| May 7, 2026 | Citigroup | Maintained | Buy | Buy |
| May 7, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| May 7, 2026 | Evercore ISI Group | Maintained | In-Line | In-Line |
| Apr 6, 2026 | Evercore ISI Group | Maintained | In-Line | In-Line |
| Feb 6, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Feb 5, 2026 | Citigroup | Maintained | Buy | Buy |
| Feb 5, 2026 | Stifel | Maintained | Hold | Hold |
| Feb 5, 2026 | TD Cowen | Maintained | Buy | Buy |
| Feb 5, 2026 | UBS | Maintained | Buy | Buy |
| Feb 5, 2026 | Evercore ISI Group | Maintained | In-Line | In-Line |
| Jan 5, 2026 | Evercore ISI Group | Downgrade | Outperform | In-Line |
| Nov 20, 2025 | Argus Research | Maintained | Buy | Buy |
| Nov 6, 2025 | UBS | Maintained | Buy | Buy |
| Nov 6, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 14, 2025 | TD Cowen | Maintained | Buy | Buy |
| Oct 7, 2025 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Sep 3, 2025 | RBC Capital | Upgrade | Sector Perform | Outperform |
| Aug 21, 2025 | Citigroup | Upgrade | Neutral | Buy |
| Aug 7, 2025 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Jul 11, 2025 | Scotiabank | Maintained | Sector Outperform | Sector Outperform |
| Jul 9, 2025 | TD Cowen | Initiated | — | Buy |
